Lag Topic – Landscape – Extrapolated Worldwide Coverage-1600685872
DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key type 1 diabetes patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download kfhkdfh
Use the Extrapolated Worldwide Coverage dashboard to do the following:
View 10-year forecasts of the diagnosed incident cases and diagnosed prevalent cases for all 171 countries, stratified by region and World Bank income status.
Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.
Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
Generate and export global heat maps of disease risk or patient population size.
The Extrapolated Worldwide Coverage dashboard is available as an Excel file in the “Downloads” section. It is available for purchase by clients who subscribe to all 45 countries covered by DRG Epidemiology. For subscription and entitlement queries, please contact DRG.support@clarivate.com.
Lag Topic - Landscape - Extrapolated Worldwide Coverage-1600685872
text test
Folder test
Etiology and Pathophysiology
Expert Insight
Disease Overview
Natural History
Classification of Atrial Fibrillation
Major Clinical Manifestations of Atrial Fibrillation
Signs and Symptoms of Atrial Fibrillation
The Cardiac Conduction System
Phases and Ionic Currents of the Human Cardiac Action Potential
Comparison of ECG Recordings from Healthy and AF Patients
Electrical Remodeling
Contractile Remodeling
Structural Remodeling
Ion Channels and Gap Junction Abnormalities
Ion-Channel Expression Changes in Human Atrial Fibrillation
Inflammatory Factors Contributing to Atrial Fibrillation
Electrophysiological Mechanisms
The Role of Genetics in Atrial Fibrillation Induction
Atrial Fibrillation Drug Targets and Rationale
Antithrombotic Drug Targets
table
text node
test
folder save
test text test
test
text node
text node
table test
test by priya
Folder test test
text
1st folder
text
Joseph Granato, M.P.H.
Joseph Granato, M.P.H., is a senior epidemiologist at DRG, part of Clarivate. Before joining DRG, he worked with the Monroe County Health Department on the surveillance of reportable diseases, including dengue fever. He received his M.P.H. from Des Moines University, where he worked on several population health projects, including tick-borne diseases. He also holds a B.S. in animal science from the University of Tennessee.
Nicole Zhang, M.P.H.
Nicole Zhang, M.P.H., is an epidemiologist at DRG, part of Clarivate. Prior to joining DRG, she worked as a research analyst at Massachusetts General Hospital, where she independently managed data from a food information survey conducted in Chelsea, Massachusetts. She has also worked for the Massachusetts Department of Public Health, conducting secondary research in the field of gestational diabetes. She holds an M.P.H. from Tufts Medical School, where she specialized in epidemiology and biostatistics. She also holds a B.A. in chemistry and statistics from Mount Holyoke College.
